<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 12 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	line-height:115%;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	font-size:8.0pt;
	font-family:"Calibri","sans-serif";}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:.5in;
	line-height:115%;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Tahoma","sans-serif";}
p.msolistparagraphcxspfirst, li.msolistparagraphcxspfirst, div.msolistparagraphcxspfirst
	{mso-style-name:msolistparagraphcxspfirst;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	line-height:115%;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";}
p.msolistparagraphcxspmiddle, li.msolistparagraphcxspmiddle, div.msolistparagraphcxspmiddle
	{mso-style-name:msolistparagraphcxspmiddle;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	line-height:115%;
	font-size:10.0pt;
	font-family:"Calibri","sans-serif";}
p.msolistparagraphcxsplast, li.msolistparagraphcxsplast, div.msolistparagraphcxsplast
	{mso-style-name:msolistparagraphcxsplast;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:.5in;
	line-height:115%;
	font-size:10.0pt;
	font-family:"Calibri","sans-serif";}
p.msochpdefault, li.msochpdefault, div.msochpdefault
	{mso-style-name:msochpdefault;
	margin-right:0in;
	margin-left:0in;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";}
span.apple-converted-space
	{mso-style-name:apple-converted-space;}
.MsoChpDefault
	{font-size:10.0pt;}
@page WordSection1
	{size:8.5in 11.0in;
	margin:1.0in 1.0in 1.0in 1.0in;
	border:none;
	border-top:solid windowtext 1.0pt;
	padding:24.0pt 0in 0in 0in;}
div.WordSection1
	{page:WordSection1;}
-->
</style>

</head>

<body lang=EN-US link=blue vlink=purple>

<div class=WordSection1>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=1414
 style='width:1060.55pt;border-collapse:collapse'>
 <tr>
  <td width=1410 colspan=4 valign=top style='width:1057.8pt;border:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='margin-right:-.25in;text-align:center'><b><span
  style='font-size:12.0pt;line-height:115%'>Case Report: Deep Transcranial
  Magnetic Stimulation (dTMS) and Improvement of Kidney Functions in a 72
  year-old female CKD patient </span></b><i><span style='font-size:10.0pt;
  line-height:115%'>Jacek Maitan (<a href="mailto:jmaitan@mvptms.com">jmaitan@mvptms.com</a>)
  2016</span></i></p>
  </td>
  <td width=4 style='width:2.75pt;padding:0in 0in 0in 0in'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
 <tr style='height:86.25pt'>
  <td width=422 valign=top style='width:4.4in;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:86.25pt'>
  <p class=MsoNormal style='margin-right:.05in;text-align:justify'><b><span
  style='font-size:10.0pt;line-height:115%'>ABSTRACT:</span></b><span
  style='font-size:10.0pt;line-height:115%'> The patient is a nonAfrican female
  72 yrs, 80 kG. Major increase of <b>eGFR</b> from 40 to 51 [mL/min/1.73] and
  reduction of <b>creatinine serum</b> from 1.35 to 1.09 [mg/dL] was detected
  after <b>24 sessions of dTMS</b> (Brainsway) of Major Depressive Disorder
  (MDD); lab tests were performed within 4 months. This case may perhaps be a
  potential indicator of functional improvement that can be gained by
  integrating psychosomatic view into the clinical practice of nephrology.</span></p>
  </td>
  <td width=212 rowspan=2 valign=top style='width:159.3pt;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:86.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal'><img border=0 width=168 height=168
  id="Picture 15" src="index_files/image001.jpg" alt=BA46.jpg></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal'><b><span style='font-size:12.0pt'>BA 46</span></b></p>
  </td>
  <td width=220 rowspan=2 valign=top style='width:165.3pt;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:86.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal'><img border=0 width=167 height=167
  src="index_files/image014.gif"
  alt="https://upload.wikimedia.org/wikipedia/commons/a/aa/Brodmann_area_46_animation_small.gif"></p>
  </td>
  <td width=555 rowspan=4 valign=top style='width:416.4pt;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:86.25pt'>
  <table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
   style='border-collapse:collapse'>
   <tr>
    <td width=283 valign=top style='width:212.55pt;padding:0in 5.4pt 0in 5.4pt'>
    <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:
    .0001pt;text-align:center;line-height:normal'><img border=0 width=231
    height=231 src="index_files/image001.gif" alt=image004.gif></p>
    <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:
    .0001pt;text-align:center;line-height:normal'><span style='font-size:
    10.0pt'>Fig. 1 Schematics of interaction between LDFC and BA 25 [image by Brainsway]</span></p>
    <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:
    .0001pt;text-align:center;line-height:normal'>&nbsp;</p>
    </td>
    <td width=283 valign=top style='width:212.55pt;padding:0in 5.4pt 0in 5.4pt'>
    <p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;
    text-align:justify;line-height:normal'><b><span style='font-size:10.0pt'>TREATMENT
    PROTOCOL:</span></b><span style='font-size:10.0pt'> Treatment follows the
    protocol recommended for MDD [1] and involves stimulation of LDFC (BA 46)
    at levels up to 120% MEP using dTMS. Studies indicated that BA 46 and BA 25
    are functionally connected (negative correlation [4], area labeled TMS2)
    and this may explain the impact of TMS on kidneys.</span></p>
    <p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;
    text-align:justify;line-height:normal'><span style='font-size:10.0pt'>&nbsp;</span></p>
    <p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;
    text-align:justify;line-height:normal'><span style='font-size:10.0pt'>Broad
    area and the depth of action provided by H1 coil used in the treatment may
    also affect other areas involved in this psychosomatic response to the dTMS
    treatment (area labeled TMS3), Fig. 1. [5] discusses issues in design of 
	    coils and the difference between TMS coils, 
	    Fig. 4 and 5.</span></p>
    </td>
   </tr>
  </table>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:normal'><span style='font-size:10.0pt'>Patient history
  Fig. 2a and 2b indicates a steady decline of renal functions. An unexpected change
  in this trend as measured by eGFR and creatinine [4] that occurred after the
  TMS. Both creatinine and eGFR improved and their values moved toward the
  normal range. These changes that coincide with TMS treatments are perhaps
  worth to notice and should be followed by a study based on a larger cohort. </span></p>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:normal'><span style='font-size:10.0pt'>&nbsp;</span></p>
  <table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
   style='border-collapse:collapse'>
   <tr>
    <td width=272 valign=top style='width:204.3pt;border:none;border-right:
    solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt'>
    <p class=MsoNormal align=center style='margin-right:1.5pt;text-align:center'><img
    border=0 width=248 height=172 src="index_files/image005.png"
    ></p>
    <p class=MsoNormal align=center style='margin-right:8.1pt;text-align:center'><b><span
    style='font-size:9.0pt;line-height:115%'>Fig 1a</span></b><span
    style='font-size:9.0pt;line-height:115%'> Patient's eCFG history</span></p>
    </td>
    <td width=295 valign=top style='width:221.55pt;padding:0in 5.4pt 0in 5.4pt'>
    <p class=MsoNormal style='margin-right:9.0pt;text-align:justify'><b><span
    style='font-size:9.0pt;line-height:115%'><img border=0 width=245
    height=192 src="index_files/fig1c.gif" alt=image007.png></span></b><b><span
    style='font-size:9.0pt;line-height:115%'>Fig 1b</span></b><span
    style='font-size:9.0pt;line-height:115%'> Serum creatinine levels vs.
    measured glomerular filtration rate (GFR) </span></p>
    </td>
   </tr>
  </table>
  </td>
  <td width=4 style='width:2.75pt;padding:0in 0in 0in 0in;height:86.25pt'></td>
 </tr>
 <tr style='height:86.25pt'>
  <td width=422 rowspan=5 valign=top style='width:4.4in;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:86.25pt'>
  <p class=MsoNormal style='margin-right:.05in;text-align:justify'><b><span
  style='font-size:10.0pt;line-height:115%'>THEORY: </span></b><span
  style='font-size:10.0pt;line-height:115%'>Cortico-adrenal circuits are a
  multisynaptic circuits that connect neurons in the motor and prefrontal areas
  of the cerebral cortex to the adrenal medulla. When <i>rabies virus</i> is injected
  into the adrenal medulla, it is transported transneuronally in the retrograde
  direction through these circuits. Depending on the survival time, the virus
  will infect first-order (1), second-order (2), third-order (3), or
  fourth-order (4) neurons.</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal'><img border=0 width=405 height=541
  src="index_files/image007.gif"
  alt="Cortical Pathways to the Adrenal Medulla.png"></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal'><b><i><span style='font-size:10.0pt'>&nbsp;</span></i></b></p>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
  justify;line-height:normal'><b><i><span style='font-size:10.0pt'>ArS,</span></i></b><i><span
  style='font-size:10.0pt'> arcuate sulcus; <b>CgS</b>, cingulate sulcus; <b>CMAs</b>,
  cingulate motor areas; <b>CS,</b> central sulcus; <b>CST</b>, corticospinal
  tract; <b>INs</b>, interneurons; <b>IPS</b>, intraparietal sulcus; LS,
  lateral sulcus; <b>M1</b>, primary motor cortex; <b>MN,</b> motoneurons; <b>PMd</b>
  and <b>PMv</b>, dorsal and ventral premotor areas; <b>PS,</b> principal
  sulcus; <b>S1</b>, primary somatosensory cortex; <b>SMA</b>, supplementary
  motor area; <b>SPN</b>s, sympathetic preganglionic neurons.[from </span></i><span
  style='font-size:10.0pt'>[2]]</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal'><i><span style='font-size:10.0pt'>&nbsp;</span></i></p>
  <p class=MsoNormal align=center style='text-align:center'><b><span
  style='font-size:10.0pt;line-height:115%;color:gray'>Gray shading</span></b><span
  style='font-size:10.0pt;line-height:115%'>, cortical motor areas; <b><span
  style='color:#00B0F0'>blue shading</span></b>, medial prefrontal areas. </span></p>
  <p class=MsoNormal style='margin-right:5.8pt;text-align:justify'><span
  style='font-size:10.0pt;line-height:115%'>In the case described in this note,
  we have treated MDD, improvement of CKD was just a side effect. Our treatment
  used a deep penetration H-coil with broad action area. This may have resulted
  in an additional side effect where a wide area of prefrontal cortex is being
  affected in a fashion which may need to be determined. </span></p>
  <p class=MsoNormal style='margin-right:5.8pt;text-align:justify'><span
  style='font-size:10.0pt;line-height:115%'>TMS area 1 (TMS1) corresponds to
  the area used in [3]. TMS areas TMS2 and TMS3 are the areas involved in
  stimulation of BA25 using Brainsway's H-coil. Stimulation using TMS BA 46
  also affects BA 25 [4] and this leads to a hypothesis that this link explains
  the effect of the treatment, this area is labeled TMS2. </span></p>
  </td>
  <td width=4 style='width:2.75pt;padding:0in 0in 0in 0in;height:86.25pt'></td>
 </tr>
 <tr style='height:127.5pt'>
  <td width=212 valign=top style='width:159.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:127.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal'><img border=0 width=164 height=164
  src="index_files/image009.jpg" alt=BA25.jpg></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal'><b><span style='font-size:12.0pt'>BA 25</span></b></p>
  </td>
  <td width=220 valign=top style='width:165.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:127.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal'><img border=0 width=171 height=171
  src="index_files/image018.gif" alt="BA25 rot.gif"></p>
  </td>
  <td width=4 rowspan=2 style='width:2.75pt;padding:0in 0in 0in 0in;height:
  127.5pt'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
 <tr style='height:127.5pt'>
  <td width=212 valign=top style='width:159.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:127.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal'><img border=0 width=169 height=169
  src="index_files/image019.jpg" alt=BA32.jpg></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal'><b><span style='font-size:12.0pt'>BA 32</span></b></p>
  </td>
  <td width=220 valign=top style='width:165.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:127.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal'><img border=0 width=174 height=174
  src="index_files/image011.gif"
  alt="https://upload.wikimedia.org/wikipedia/commons/8/8c/Brodmann_area_32_animation_small.gif"></p>
  </td>
 </tr>
 <tr>
  <td width=212 valign=top style='width:159.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal'><img border=0 width=174 height=174
  src="index_files/image020.jpg" alt=BA24.jpg></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal'><b><span style='font-size:12.0pt'>BA 24</span></b></p>
  </td>
  <td width=220 valign=top style='width:165.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal'><img border=0 width=176 height=176
  src="index_files/image013.gif" alt="BA24 rot.gif"></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal'><span style='font-size:8.0pt'>(3D brain
  data is from Anatomography.)</span></p>
  </td>
  <td width=555 rowspan=2 valign=top style='width:416.4pt;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-left:2.3pt;text-align:justify'><b><span
  style='font-size:10.0pt;line-height:115%'>DISCUSSION:</span></b><span
  style='font-size:10.0pt;line-height:115%'> TMS stimulation of motor cortex
  and its impact on kidneys has been explored on the premise that there is a
  afferent link with renal control. A figure-of-eight coil set up at 90% of
  motor evoked potential (MEP) has been applied to stimulate motor cortex of diabetic
  patients (area labeled TMS1) and as a result proteinuria and albuminuria were
  improved after 5 treatments [3]. </span></p>
  <p class=MsoNormal style='margin-left:2.3pt;text-align:justify'><span
  style='font-size:10.0pt;line-height:115%'>The case described here indicates
  that perhaps stimulation of prefrontal part of cortico-adrenal circuits can
  be achieved in an FDA approved protocol for MDD treatment using TMS. This
  also confirms the clinical value of the model described in [2, 4]. If the hypotesis 
	  presented here will be confirmed, then a treatment protocol combining the
	  approach described in [3] offers perhaps a novel and effective approach 
	  to some cases of CKD.</span></p>
  <p class=MsoNormal style='margin-left:2.3pt;text-align:justify'><span
  style='font-size:10.0pt;line-height:115%'>The collocation of neural
  mechanisms controlling autonomous and emotional state may explain the impact
  of the treatment on both function of kidneys and depression. The existence of
  emotional problems in CKD patients in dialysis has been reported. Thus, it
  seems there is perhaps a need for augmenting CKD treatment to include mental
  component, TMS which is a non-pharmacological, non-invasive treatment of MDD
  may perhaps be also a right auxiliary treatment of their autonomous functions
  including kidneys. An open question to be answered by a lerge scale studies is 
	whether in cases of CKD patients, MDD diagnosis is
  necessary to start the TMS treatment.</span></p>
  <p class=MsoNormal style='margin-left:2.3pt;text-align:justify'><b><span
  style='font-size:10.0pt;line-height:115%'>References:</span></b></p>
  <p class=MsoListParagraph style='margin-left:9.0pt;text-indent:-9.0pt'><span
  style='font-size:8.0pt;line-height:115%'>1.</span><span style='font-size:
  7.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&nbsp; </span><span
  style='font-size:8.0pt;line-height:115%'>T. Perera et al, <b>The Clinical TMS
  Society Consensus Review and Treatment Recommendations for TMS Therapy for Major
  Depressive Disorder</b>, <i>Brain Stimulation</i>, MayâJune, 2016Volume 9,
  Issue 3, Pages 336â346, </span></p>
  <p class=MsoListParagraph style='margin-left:9.0pt;text-indent:-9.0pt'><span
  style='font-size:8.0pt;line-height:115%'>2.</span><span style='font-size:
  7.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&nbsp; </span><span
  style='font-size:8.0pt;line-height:115%'>Richard P. Dum et al, <b>Motor,
  cognitive, and affective areas of the cerebral cortex influence the adrenal
  medulla</b>, <i>PNAS submission</i> March 2016, </span></p>
  <p class=MsoListParagraph style='margin-left:9.0pt;text-indent:-9.0pt'><span
  style='font-size:8.0pt;line-height:115%'>3.</span><span style='font-size:
  7.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&nbsp; </span><span
  style='font-size:8.0pt;line-height:115%'>Rosaria Lupica, et al, <b>Proteinuric
  effect of transcranial magnetic stimulation in healthy subjects and diabetic
  patients with Stage 3â4 CKD</b>, <i>Nephrol Dial Transplant</i> (2013) </span></p>
  <p class=MsoListParagraph style='margin-left:9.0pt;text-indent:-9.0pt'><span
  style='font-size:10.0pt;line-height:115%'>4.</span><span style='font-size:
  7.0pt;line-height:115%;font-family:"Times New Roman","serif"'> </span><span
  style='font-size:8.0pt;line-height:115%;color:#252525;background:white'>Fox,
  MD; at all (2012). <b>Efficacy of transcranial magnetic stimulation targets for
  depression is related to intrinsic functional connectivity with the subgenual
  cingulate</b>.<span class=apple-converted-space>&nbsp;</span><i>Biological
  Psychiatry</i>.<span class=apple-converted-space>&nbsp;</span><b>72</b><span
  class=apple-converted-space>&nbsp;</span>(7): 595â603.</span><span
  class=apple-converted-space><span style='font-size:10.0pt;line-height:115%;
  color:#252525;background:white'>&nbsp;</span></span><span style='font-size:
  10.0pt;line-height:115%'> </span></p>
  <p class=MsoListParagraph style='margin-left:9.0pt;text-indent:-9.0pt'><span
  style='font-size:8.0pt;line-height:115%'>5. Zhi-De Deng<b>, Coil Design
  Considerations for Deep Transcranial Magnetic Stimulation</b>, </span><span
  style='font-size:8.0pt;line-height:115%;font-family:"Arial","sans-serif";
  color:black;background:#F8F8F8'>Clin Neurophysiol. 2014 June; 125(6):
  1202:1212</span></p>
  <p class=MsoNormal><b><i><span style='font-size:10.0pt;line-height:115%'>This
  draft material is for private distribution only. For comments and interest in
  participating in a larger study please&nbsp; send an <a
  href="mailto:jmaitan@mvptms.com">email</a>. .</span></i></b><i><span
  style='font-size:10.0pt;line-height:115%'>Rev. 0.5 Nov.28.2016</span></i></p>
  </td>
  <td width=4 style='width:2.75pt;padding:0in 0in 0in 0in'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=212 valign=top style='width:159.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal'>&nbsp;</p>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal'><img border=0 width=107 height=267
  src="index_files/image022.jpg"></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal'>&nbsp;</p>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal'>Fig. 4  Brainsway H-coil has a deep and broad
  field of stimulation [5]</p>
  </td>
  <td width=220 valign=top style='width:165.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal'><img border=0 width=120 height=285
  src="index_files/image024.jpg"></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal'>&nbsp;</p>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal'>Fig. 5  Figure-8 coil a smaller spot and depth
  of stimulation [5]</p>
  </td>
  <td width=4 style='width:2.75pt;padding:0in 0in 0in 0in'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
</table>

<p class=MsoNormal><b><span style='font-size:12.0pt;line-height:115%'>&nbsp;</span></b></p>

<p class=MsoNormal>&nbsp;</p>

</div>

</body>

</html>
